1. Home
  2. XOMA vs MMD Comparison

XOMA vs MMD Comparison

Compare XOMA & MMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMA
  • MMD
  • Stock Information
  • Founded
  • XOMA 1981
  • MMD 2012
  • Country
  • XOMA United States
  • MMD United States
  • Employees
  • XOMA N/A
  • MMD N/A
  • Industry
  • XOMA Biotechnology: Pharmaceutical Preparations
  • MMD Investment Managers
  • Sector
  • XOMA Health Care
  • MMD Finance
  • Exchange
  • XOMA Nasdaq
  • MMD Nasdaq
  • Market Cap
  • XOMA 330.2M
  • MMD 274.9M
  • IPO Year
  • XOMA N/A
  • MMD N/A
  • Fundamental
  • Price
  • XOMA $37.86
  • MMD $15.41
  • Analyst Decision
  • XOMA Strong Buy
  • MMD
  • Analyst Count
  • XOMA 2
  • MMD 0
  • Target Price
  • XOMA $69.50
  • MMD N/A
  • AVG Volume (30 Days)
  • XOMA 57.8K
  • MMD 74.7K
  • Earning Date
  • XOMA 11-06-2025
  • MMD 01-01-0001
  • Dividend Yield
  • XOMA N/A
  • MMD 4.88%
  • EPS Growth
  • XOMA N/A
  • MMD N/A
  • EPS
  • XOMA N/A
  • MMD N/A
  • Revenue
  • XOMA $44,952,000.00
  • MMD N/A
  • Revenue This Year
  • XOMA $82.30
  • MMD N/A
  • Revenue Next Year
  • XOMA $12.59
  • MMD N/A
  • P/E Ratio
  • XOMA N/A
  • MMD N/A
  • Revenue Growth
  • XOMA 194.98
  • MMD N/A
  • 52 Week Low
  • XOMA $18.35
  • MMD $14.30
  • 52 Week High
  • XOMA $38.00
  • MMD $17.67
  • Technical
  • Relative Strength Index (RSI)
  • XOMA 75.26
  • MMD 78.54
  • Support Level
  • XOMA $33.59
  • MMD $15.27
  • Resistance Level
  • XOMA $38.00
  • MMD $15.48
  • Average True Range (ATR)
  • XOMA 1.62
  • MMD 0.13
  • MACD
  • XOMA 0.15
  • MMD 0.09
  • Stochastic Oscillator
  • XOMA 97.66
  • MMD 93.00

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

About MMD MainStay MacKay DefinedTerm Municipal Opportunities Fund

NYLI MacKay DefinedTerm Muni Opportunities Fund is a USA-based diversified closed-end management investment company. The fund's investment objective is to seek current income exempt from regular U.S. Federal income taxes as well as total return. The company predominantly invests in municipal bonds, the interest on which is, in the opinion of bond counsel to the issuers, generally excludable from gross income for regular U.S. Federal income tax purposes.

Share on Social Networks: